These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence of secondary dapsone resistance in Nepal. Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344 [TBL] [Abstract][Full Text] [Related]
6. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411 [No Abstract] [Full Text] [Related]
7. Primary dapsone-resistant leprosy in Cebu, Philippines. Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607 [TBL] [Abstract][Full Text] [Related]
8. Primary dapsone resistant leprosy in Nepal. Samuel NM; Samuel S; Loudon J; Adiga RB Indian J Lepr; 1984; 56(4):819-22. PubMed ID: 6398343 [TBL] [Abstract][Full Text] [Related]
9. The problem of dapsone-resistant leprosy. Pearson JM Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605 [No Abstract] [Full Text] [Related]
10. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. Walker LL; Van Landingham RM; Shinnick TM Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182 [TBL] [Abstract][Full Text] [Related]
12. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335 [TBL] [Abstract][Full Text] [Related]
13. Combinations of drugs against Mycobacterium leprae studied in mice. Shepard CC Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383 [No Abstract] [Full Text] [Related]
16. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India). Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340 [TBL] [Abstract][Full Text] [Related]
17. Dormancy, drug resistance or dependency; some thoughts to ponder. Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116 [No Abstract] [Full Text] [Related]
18. Recent advances in the study of the leprosy bacillus. Rees RJ Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843 [No Abstract] [Full Text] [Related]
19. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997. Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888 [TBL] [Abstract][Full Text] [Related]
20. Secondary sulphone resistance in leprosy (Report of a case). Lal S; Jaganath C; Garg BR; Paneerselvam R Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]